Johnson & Johnson to expand dermatology portfolio with $850m Proteologix acquisition
The company will gain access to two treatments for atopic dermatitis
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Study reveals new breast cancer genes found in women of African ancestry
More than 240,000 cases of breast cancer are diagnosed in the US every year
Johnson & Johnson to expand dermatology portfolio with $850m Proteologix acquisition
The company will gain access to two treatments for atopic dermatitis
Governments continue proposed pandemic agreement progress ahead of World Health Assembly
The meeting focusing on ‘All for Health, Health for All’ takes place on 27 May to 7 June 2024
GSK becomes first founding partner of global initiative tackling antimicrobial resistance
AMR could cause an estimated ten million deaths every year by 2050 unless action is taken
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Latest content
Gilead Sciences appoints Peter Wickersham to vice-president and general manager in the UK and Ireland
Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US
Read More
Havas Life Medicom and Sciterion appoint Dick Dunford as group creative director
Dunford recently served as executive creative director at TBWA\WorldHealth
Read More
Intelligence
Achieving patient-guided drug development: putting the patient experience first
Why understanding all aspects of the patient journey is imperative to successful clinical research
Read More
Data integration and the AI healthcare revolution
Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK
Read More
Is the gut microbiome the next frontier in medicine?
Research has long shown a strong connection between disease and the gut microbiome
Read More
Current trends and the renaissance of Alzheimer’s drug development
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read More
Rare diseases – raising awareness, listening to patients, making a difference
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read More
Behavioural science – the route to healthcare salvation?
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read More
Blogs
Latest
Empowering Nurses Through Education
May 17, 2024 | Medscape Education Global|CME, Education, Nursing, medical education
Nurse education is powerful and makes an impact.
Pioneering Paths: Women Leadership in Rare Disease
May 15, 2024 | Medscape Education Global|Women in healthcare, daretothinkrare, rare disease
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there …
NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar
May 7, 2024 | Mtech Access|GP contract, Market Access, NHS, NHS Whispers, Operational Planning Guidance, primary care
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract …
Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success
May 3, 2024 | Innovative Trials|Patient Retention, clinical trials, patient engagement, patient recruitment, pharmaceutical industry
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
May 2, 2024 | Medscape Education Global|
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data …
Exploring medical education and why it relies on real-world research
May 16, 2024 | Onyx Health|HCP engagement, MedEd, healthcare communications, medical education
Onyx Health’s Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own
Beyond the AI anxiety: The impact of human intuition
May 7, 2024 | Mednet Group|AI, Innovation, Project Management, artificial intelligence, thought leadership
Explore the ways we’re adapting to work with AI, not against it
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Impetus Digital|Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The role of economic evaluation in US healthcare
April 30, 2024 | Mtech Access|AMCP, Health Economics, ICER, US healthcare, USA, health economic evaluation
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight …
Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
Enhancing Virtual Training: Role-Playing in Meetings – Impetus InSite Tips #7
May 16, 2024 | Impetus Digital | Advisory board, DOL, DOL engagement, HCP engagement, HCP platform, Impetus Digital, KOL, KOL Engagement, Pharma meeting, Pharma tips, Pharma trends, Virtual Meeting, Virtual collaboration, insight gathering